Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-South Africa to ramp up COVID-19 vaccinations as opposition protests

Fri, 25th Jun 2021 14:08

(Updates with EFF march)

JOHANNESBURG, June 25 (Reuters) - Several thousand
supporters of a leftist party demonstrated outside the offices
of South Africa's health regulator on Friday to protest against
the slow coronavirus vaccine roll-out in Africa's worst-hit
country.

The protesters from the Economic Freedom Fighters (EFF) held
aloft placards and flags but few wore protective masks, a
Reuters photographer said.

Their march to the offices defied rules meant to curb a
third wave of infections. They demanded that Russian and Chinese
vaccines be authorised to speed up the vaccination process.

Officials said that South Africa - which has recorded more
than 1.8 million COVID-19 cases and more than 59,000 deaths -
aimed to double daily vaccinations in the next month.

Acting health minister Mmamoloko Kubayi-Ngubane said at a
news conference that it was irresponsible to hold marches and
other large gatherings while infections were surging.

South Africa's immunisation efforts were set back by the
revelation that AstraZeneca's vaccine is much less
effective against the dominant local coronavirus variant, and
the government subsequently found it hard to access supplies
from other manufacturers.

So far, only 2.5 million vaccinations have been administered
using either the one-shot Johnson & Johnson (J&J)
vaccine or the two-shot Pfizer alternative, out of a
population of 60 million people.

Nicholas Crisp, a senior health official, said more than
100,000 people had been vaccinated per day in the last two days
and the target for next week was 150,000 a day. The aim for
mid-July was 200,000, and 250,000 by the end of that month.

"The president has asked us to chase a target of 300,000 a
day," he said.

Kubayi-Ngubane said Pfizer had delivered nearly 4.5 million
vaccine doses in the second quarter and had committed to provide
just over 15.5 million doses in the third quarter.

J&J has delivered 500,000 shots for a research study
targeting healthcare workers, 300,000 last week and 1.2 million
on Thursday, Kubayi-Ngubane said.

A further 500,000 J&J doses are expected soon, but the
timing is not yet confirmed.

"With this flow of vaccines, we will be able to press ahead
with the vaccination of frontline workers sector by sector," she
said.

South Africa has started immunising health workers, those
aged over 60 years and education sector employees. From July 15
the over-50s will start getting the vaccine, she said.

(Reporting by Alexander Winning and Akhona Matshoba in
Johannesburg, and Siphiwe Sibeko in Pretoria, editing by Louise
Heavens and Angus MacSwan)

More News
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.